For countless families grieving the loss of a loved one to suicide, one haunting question returns again and again: “How did we not see this coming?” A new study suggests that, in many cases, there truly may have been no obvious signs to notice. 

Researchers at the University of Utah have found that a large number of people who die by suicide never show traditional warning signals—no previous attempts, no expressed suicidal thoughts, and often no diagnosed mental health conditions. 

The findings, published in JAMA Network Open, challenge long-standing beliefs about who is at risk and how prevention strategies should be shaped.

The study highlights that nearly half of all individuals who die by suicide have no known history of suicidal thoughts or behaviour.

Many also lack diagnoses of depression, anxiety, or other psychiatric conditions typically linked to suicide. 

To understand this often-invisible group, researchers examined anonymised genetic data from more than 2,700 people who died by suicide. 

They discovered that those without prior warning signs tended to have fewer psychiatric diagnoses and fewer genetic risk factors associated with depression, anxiety, PTSD, Alzheimer’s disease, and related conditions. 

Surprisingly, this group was no more likely than the general population to show personality traits such as chronic low mood or neuroticism.

Hilary Coon, the study’s lead author and a professor of psychiatry at the University of Utah, explained that the absence of symptoms is not simply a matter of families or clinicians “missing” them. In many cases, she said, individuals at risk may not actually appear depressed at all. This insight widens the lens on suicide prevention, suggesting that risk may present itself in more complex ways than previously understood.

For decades, suicide prevention efforts have centred heavily on detecting depression and related mental health disorders. But the Utah findings indicate that this approach may fail to reach a large segment of people who are nonetheless vulnerable. 

Coon noted that while enhanced screening can help identify risk among those with typical underlying vulnerabilities, it may not offer much protection for individuals whose risks stem from other biological or medical pathways. In such cases, the absence of depression or visible distress means current screening tools may simply not detect them.

The research team is now exploring additional factors that might raise suicide risk within this overlooked group, including chronic pain, inflammation, and respiratory illnesses. They are also examining what makes some individuals resilient despite difficult life conditions, in hopes of understanding protective mechanisms that could guide future interventions. Coon emphasised that there is no single gene responsible for suicide, underscoring instead the complex interaction between biology, environment, and health.

Ultimately, the researchers hope their work will help doctors recognise high-risk individuals earlier, even when they do not express suicidal thoughts or exhibit classic warning signs. 

Coon noted that certain clinical conditions may make people especially vulnerable in certain environmental contexts, yet they may never openly mention feeling suicidal. 

By identifying these hidden patterns, she believes health professionals can intervene more precisely and effectively.

As global suicide rates continue to rise, this study serves as a powerful reminder that prevention must be broader and more nuanced than it is today. The findings call for a new generation of strategies—ones that look beyond conventional mental health indicators and recognise the diverse, often silent pathways that may lead a person to crisis.